Peptides I: Recovery & Inflammation, Minus the Hype

Interest in peptides for recovery and healthy inflammation support is moving faster than the research behind them, and the research varies widely from one compound to the next. In the first session of our three-part peptide series, we'll look at BPC-157, TB-500, and KPV: how they're proposed to work, what's been studied, and where the big questions remain.

Patients are already asking about these compounds. You'll leave with a clearer sense of what the research does and doesn't support, so you can answer those questions clearly and confidently.

This webinar is designed for:

• Functional and integrative medicine providers following peptide research
• Sports medicine clinicians interested in recovery-related research
• Providers who want clarity on emerging research and its limitations
• Prescribers seeking context for patient questions about these peptides

You’ll learn how to:

• Explain the proposed mechanisms of BPC-157, TB-500, and KPV
• Distinguish peptide-specific findings from research on related molecules
• Identify where the evidence is largely preclinical and where human data is still limited
• Recognize key risk, targeting with dosage forms and dosing, and regulatory considerations, including why these compounds aren't currently available for compounding

Disclaimer: Prescription required. Compounded medications are not approved by the FDA for safety or efficacy. Statements not evaluated by the FDA. For informational use; not medical advice. The following information reflects Strive Pharmacy's exploratory research and development (R&D) formulation efforts. No medications will be compounded for patient use without FDA authorization and regulatory clearance of the applicable APIs.